We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $832M
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
-1.51%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
–
AUM
$4.67B
AUM Growth
-$124M
Cap. Flow
+$341M
Cap. Flow %
7.3%
Top 10 Hldgs %
73.2%
Holding
76
New
12
Increased
8
Reduced
8
Closed
12

Top Buys

Rank Stock Value
1
SE icon
Sea Limited
SE
+$248M
2
BABA icon
Alibaba
BABA
+$185M
3
DQ
Daqo New Energy
DQ
+$88.6M
4
PDD icon
Pinduoduo
PDD
+$65.6M
5
DASH icon
DoorDash
DASH
+$64.3M

Top Sells

Rank Stock Value
1
LEGN icon
Legend Biotech
LEGN
+$106M
2
IQ icon
iQIYI
IQ
+$93.5M
3
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
+$92.1M
4
ONON icon
On Holding
ONON
+$67.1M
5
LI icon
Li Auto
LI
+$64.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 40.38%
2 Healthcare 32.21%
3 Technology 16.3%
4 Consumer Staples 4%
5 Real Estate 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROOT icon
51
Root
ROOT
$839M
$3.09M 0.07%
144,444
– –
PRLD icon
52
Prelude Therapeutics
PRLD
$354M
$3.04M 0.07%
583,333
– –
BEDU
53
DELISTED
Bright Scholar Education Holdings
BEDU
$2.91M 0.06%
996,449
– –
ALGS icon
54
Aligos Therapeutics
ALGS
$31.7M
$2.86M 0.06%
94,603
– –
PATH icon
55
UiPath
PATH
$7.62B
$2.73M 0.06%
150,000
– –
MNSO icon
56
MINISO
MNSO
$2.64B
$1.98M 0.04%
252,322
– –
MOGU
57
MOGU Inc
MOGU
$15.4M
$1.96M 0.04%
870,580
– –
CCC
58
CCC Intelligent Solutions
CCC
$3.95B
$1.84M 0.04%
200,000
– –
PYXS icon
59
Pyxis Oncology
PYXS
$279M
$1.82M 0.04%
764,406
– –
TRML
60
DELISTED
Tourmaline Bio
TRML
$1.2M 0.03%
26,615
-43,265
-62% -$3.41M
RDGT
61
Ridgetech Inc
RDGT
$2.96M
$887K 0.02%
134
– –
UXIN
62
Uxin Ltd
UXIN
$244M
$805K 0.02%
19,156
-3,817
-17% -$229K
LEAP.U
63
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
$498K 0.01%
50,000
– –
SRZNW
64
DELISTED
Surrozen Inc Warrant
SRZNW
$77K ﹤0.01%
399,999
– –
ARGX icon
65
argenx
ARGX
$62.3B
– –
-120,000
Closed -$37.8M
FUTU icon
66
Futu Holdings
FUTU
$15.4B
– –
-130,000
Closed -$4.23M
HIPO icon
67
Hippo Holdings
HIPO
$847M
– –
-110,868
Closed -$5.52M
LI icon
68
Li Auto
LI
$11.5B
– –
-2,496,550
Closed -$64.4M
MREO
69
Mereo BioPharma
MREO
$45.1M
– –
-2,976,121
Closed -$3.33M
TCRX icon
70
TScan Therapeutics
TCRX
$21.3M
– –
-669,513
Closed -$1.88M
TIL icon
71
Instil Bio
TIL
$49.4M
– –
-119,273
Closed -$25.6M
TNGX icon
72
Tango Therapeutics
TNGX
$4.04B
– –
-882,088
Closed -$6.69M
ZTO icon
73
ZTO Express
ZTO
$15.5B
– –
-200,000
Closed -$5M
CIH
74
DELISTED
China Index Holdings Limited American Depository Shares
CIH
– –
-300,000
Closed -$330K
DIDI
75
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
– –
-36,834,320
Closed -$92.1M
1 2
3
4

Similar funds

ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $832M AUM 5.47% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $832M AUM 49.88% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
AFA
AA Financial Advisors Columbus, Ohio $832M AUM 20.55% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $833M AUM 25.55% 1-Year Est. Return
AFA
American Financial Advisors Marietta, Georgia $831M AUM 21.38% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $833M AUM 22.71% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $835M AUM 73.7% 1-Year Est. Return

HHLR Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, HHLR Advisors held 76 positions worth $4.67B, down 2.6% from $4.79B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

HHLR Advisors deployed $341M of net new capital in Q2 2022, opening 12 new positions and adding to 8 existing holdings. Its largest new stake was Alibaba: 1,891,000 shares worth $215M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, up from 36% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Legend Biotech, an estimated $106M trimmed.

  • HHLR Advisors's largest Q2 2022 buy was Alibaba: 1,891,000 shares worth $215M.
  • HHLR Advisors added most to Sea Limited in Q2 2022, an estimated $248M increase.
  • HHLR Advisors's biggest Q2 2022 reduction was Legend Biotech, cutting an estimated $106M.
  • HHLR Advisors fully exited DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share in Q2 2022, selling an estimated $92.1M.
  • HHLR Advisors's ten largest holdings make up 73% of its $4.67B portfolio in Q2 2022.
  • HHLR Advisors opened 12 new positions and closed 12 in Q2 2022.
  • HHLR Advisors's portfolio value fell 2.6% quarter-over-quarter to $4.67B.

Based on HHLR Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.